Phoebe Tsou

2/2
Next steps:
* new immunological associations were highlighted in PBC, warranting further validation studies in bigger cohorts;
* functional studies are needed to investigate these novel biomarkers as suitable immunotherapy targets for PBC treatment.

21.01.2025 16:12 — 👍 2    🔁 0    💬 0    📌 0

1/2
Results: increased soluble #HVEM, #interferon #IFN-λ3, #IFN-γ, and #gut barrier permeability significantly differentiated disease stages and UDC response groups.

21.01.2025 16:12 — 👍 2    🔁 0    💬 1    📌 0

Soluble Herpes Virus Entry Mediator and Type II/III Interferons Are Upregulated in Primary Biliary Cholangitis Bacterial translocation-induced inflammation and immune dysfunction are recognised factors contributing to the pathogenesis of primary biliary cholangitis (PBC). However, the specific involvement of i...

So happy to announce my first 1st-author publication, on immunological signatures of disease severity and response to #ursodeoxycholate (UDC) in #PrimaryBiliaryCholangitis (#PBC)

doi.org/10.3390/ijms26020605

@drantonioriva.bsky.social @inst-of-liver.bsky.social

21.01.2025 16:12 — 👍 3    🔁 0    💬 1    📌 2